Real-world observational cohort study of treatment patterns and safety outcomes of infliximab biosimilar CT-P13 for the treatment of inflammatory bowel disease (CONNECT-IBD)

Volume 23, Issue 8, July - December 2023 .

Source: Expert Opinion on Biological Therapy - April 17, 2023 Category: Drugs & Pharmacology Authors: Bernd BokemeyerTibor HlavatyMatthieu AllezPamela SelemaShahrzad MoosaviMary Jane CadatalHeather FowlerMarkus MuellerKatherine F LiauJavier P Gisberta Interdisciplinary Crohn Colitis Centre Minden, Minden, Germanyb 5th Department of Internal Medicine, Sub- Source Type: research